<Record>
<Term>Neuromuscular Junction Diseases</Term>
<SemanticType>Disease or Syndrome</SemanticType>
<ParentTerm>Neuromuscular Diseases</ParentTerm>
<ClassificationPath>Nervous System Diseases/Neuromuscular Diseases/Neuromuscular Junction Diseases</ClassificationPath>
<BroaderTerm>Neuromuscular Diseases</BroaderTerm>
<BroaderTerm>Neuromuscular Junction Diseases</BroaderTerm>
<BroaderTerm>Nervous System Diseases</BroaderTerm>
<ChildTerm>Botulism</ChildTerm>
<ChildTerm>Lambert-Eaton Myasthenic Syndrome</ChildTerm>
<ChildTerm>Myasthenic Syndromes, Congenital</ChildTerm>
<ChildTerm>Myasthenia Gravis</ChildTerm>
<Synonym>Neuromuscular Junction Diseases</Synonym>
<Synonym>Neuromuscular Junction Disease</Synonym>
<Synonym>Neuromuscular Transmission Disorders</Synonym>
<Synonym>Neuromuscular Transmission Disorder</Synonym>
<Synonym>Neuromuscular Junction Disorders</Synonym>
<Synonym>Neuromuscular Junction Disorder</Synonym>
<Synonym>Neuromuscular Junction Toxic Disorders</Synonym>
<Description>Conditions characterized by impaired transmission of impulses at the NEUROMUSCULAR JUNCTION. This may result from disorders that affect receptor function, pre- or postsynaptic membrane function, or ACETYLCHOLINESTERASE activity. The majority of diseases in this category are associated with autoimmune, toxic, or inherited conditions.</Description>
<Source>MeSH</Source>
</Record>
